Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile?

The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged≥40 years. We reviewed our data in our ovulation indu...

Full description

Saved in:
Bibliographic Details
Published inHuman reproduction (Oxford) Vol. 11; no. 5; pp. 1109 - 1112
Main Authors Corsan, G., Trias, A., Trout, S., Kemmann, E.
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.05.1996
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged≥40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged ≥40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged ≥43 years. The ongoing/viable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% percycle respectively. When utilized in women aged≥40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40–42 years of age. Women≥43 years should consider other alternatives such as adoption or egg donation.
AbstractList The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged >/=40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged >/=40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged >/=43 years. The ongoing/variable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% per cycle respectively. When utilized in women aged >=40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40-42 years of age. Women >/=43 years should consider other alternatives such as adoption or egg donation.
The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged≥40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged ≥40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged ≥43 years. The ongoing/viable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% percycle respectively. When utilized in women aged≥40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40–42 years of age. Women≥43 years should consider other alternatives such as adoption or egg donation.
Abstract The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged≥40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged ≥40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged ≥43 years. The ongoing/viable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% percycle respectively. When utilized in women aged≥40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40-42 years of age. Women≥43 years should consider other alternatives such as adoption or egg donation.
The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased in recent years. Little is known regarding the efficacy of this treatment in women aged >/=40 years. We reviewed our data in our ovulation induction with IUI programme for 168 consecutive patients aged >/=40 years undergoing a total of 469 cycles of treatment. Either sequential clomiphene citrate and human menopausal gonadotrophins or daily gonadotrophins were utilized along with timed IUI insemination. In 402 completed cycles, 28 clinical pregnancies occurred. The pregnancy loss rate was 34.4%. The overall ongoing/viable pregnancy rates per initiated and completed cycles were 4.47 and 5.22% respectively. No viable pregnancies occurred in 136 cycles in women aged >/=43 years. The ongoing/variable cycle fecundity rates for women aged 40, 41, and 42 years were 9.6, 5.2, and 2.4% per cycle respectively. When utilized in women aged >=40 years, ovulation induction with IUI is most likely to result in successful pregnancy in women 40-42 years of age. Women >/=43 years should consider other alternatives such as adoption or egg donation.
Author Trias, A.
Trout, S.
Corsan, G.
Kemmann, E.
Author_xml – sequence: 1
  givenname: G.
  surname: Corsan
  fullname: Corsan, G.
  organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Reproductive Endocrinology & Infertility, UMDNJ-Robert Wood Johnson Medical School 303 George Street, Suite 250, New Brunswick, New Jersey 08901, USA
– sequence: 2
  givenname: A.
  surname: Trias
  fullname: Trias, A.
  organization: Centro Medico Docente La Trinidad, Av. Intercomunal La Trinidad, EI Hatillo, Apdo. Postal 80474 Caracas 1080-A, Venezuela
– sequence: 3
  givenname: S.
  surname: Trout
  fullname: Trout, S.
  organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Reproductive Endocrinology & Infertility, UMDNJ-Robert Wood Johnson Medical School 303 George Street, Suite 250, New Brunswick, New Jersey 08901, USA
– sequence: 4
  givenname: E.
  surname: Kemmann
  fullname: Kemmann, E.
  organization: Department of Obstetrics, Gynecology, and Reproductive Sciences, Division of Reproductive Endocrinology & Infertility, UMDNJ-Robert Wood Johnson Medical School 303 George Street, Suite 250, New Brunswick, New Jersey 08901, USA
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3120779$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/8671400$$D View this record in MEDLINE/PubMed
BookMark eNqVUMFu1DAUtFBR2RY-AckH4JbFjhPHRkIIrYAiVi2HIiEu1ktssy6JvbUTtv17DAkrceRij-fNPI_mDJ344A1CzylZUyLZy3BnQ9Q3YYoe-rTeTUM0-zUQKhnhD9CKVpwUJavJCVqRkouCUk4fobOUbgjJUPBTdCp4QytCVuj26ufUw-iCx87rqfuDujC0zhuND27cZX6MMI0mZio_khmc_-vAhzAYjyuC7w3EhIPF8N1g8BqHXpv4CruE3Zhlcdwddq43bx6jhzYHN0-W-xx9ef_uenNRbK8-fNy83RZdJelYgAVWMya4tm2XqYysFSzH1lQSUst8gDRMWt3qhnBdt1LzkoIE0Yga2Dl6Me_dx3A7mTSqwaXO9D14E6akGlHSqmE0C1_Pwi6GlKKxah_dAPFeUaJ-V67-rVzNlaul8ux_unw0tYPRR_fScZ4_W-aQOuhtBN-5dJQxWpKmkVkmZlmY9v-doJitLo3m7miG-EPxhjW1uvj6TV1uri-3ovqsPrFf8c24hw
CODEN HUREEE
CitedBy_id crossref_primary_10_1016_j_rbmo_2011_11_007
crossref_primary_10_1007_s00129_007_2052_1
crossref_primary_10_1016_S1472_6483_10_61069_3
crossref_primary_10_1016_j_bpobgyn_2006_09_004
crossref_primary_10_1016_j_gyobfe_2010_02_014
crossref_primary_10_1016_S1521_6934_02_00146_3
crossref_primary_10_1007_s12522_016_0241_0
crossref_primary_10_1007_s10815_008_9273_7
crossref_primary_10_1016_S0015_0282_02_03168_0
crossref_primary_10_1016_j_gyobfe_2007_02_028
crossref_primary_10_1016_j_fertnstert_2006_08_024
crossref_primary_10_1016_j_fertnstert_2004_05_032
crossref_primary_10_1016_S0889_8529_03_00046_X
crossref_primary_10_1007_s10815_013_9980_6
crossref_primary_10_1016_j_maturitas_2011_07_003
crossref_primary_10_1016_S0015_0282_00_01631_9
crossref_primary_10_1515_ijamh_2021_0073
crossref_primary_10_1016_S0015_0282_97_81514_2
crossref_primary_10_1007_s10304_013_0578_y
crossref_primary_10_36106_ijsr_1638275
crossref_primary_10_1007_s10815_020_01976_3
crossref_primary_10_1080_1464770312331368923
crossref_primary_10_1016_S0015_0282_99_00300_3
crossref_primary_10_1016_S0015_0282_02_03212_0
crossref_primary_10_1016_S0368_2315_10_70027_2
crossref_primary_10_1111_j_1479_828X_2010_01232_x
crossref_primary_10_1016_j_maturitas_2014_02_014
crossref_primary_10_1016_j_fertnstert_2009_02_040
crossref_primary_10_1007_s15006_012_0928_z
crossref_primary_10_1007_s10815_022_02551_8
crossref_primary_10_1016_S0301_2115_99_00260_2
ContentType Journal Article
Copyright European Society for Human Reproduction and Embryology 1996
1996 INIST-CNRS
Copyright_xml – notice: European Society for Human Reproduction and Embryology 1996
– notice: 1996 INIST-CNRS
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1093/oxfordjournals.humrep.a019306
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1460-2350
EndPage 1112
ExternalDocumentID 10_1093_oxfordjournals_humrep_a019306
8671400
3120779
10.1093/oxfordjournals.humrep.a019306
ark_67375_HXZ_NCTNL84P_K
Genre Journal Article
GroupedDBID ---
-E4
.2P
.55
.GJ
.I3
.XZ
.ZR
0R~
1TH
29I
2WC
3O-
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6.Y
70D
AABJS
AABMN
AABZA
AACZT
AAESY
AAIMJ
AAIYJ
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUQX
AAVAP
AAVLN
AAWDT
AAYOK
ABEUO
ABIXL
ABJNI
ABKDP
ABMNT
ABNHQ
ABNKS
ABPTD
ABQLI
ABQTQ
ABSAR
ABSMQ
ABWST
ABXVV
ABZBJ
ACCCW
ACFRR
ACGFS
ACIMA
ACMRT
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEIU
ADEYI
ADEZT
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADORX
ADQLU
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKPW
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFZL
AFGWE
AFIYH
AFOFC
AFXAL
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIJHB
AIKOY
AIMBJ
AJEEA
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ANFBD
APIBT
APWMN
AQDSO
AQKUS
AQVPL
ARIXL
ASAOO
ASMCH
ASPBG
ATDFG
ATTQO
AVNTJ
AVWKF
AWCFO
AXUDD
AYOIW
AZFZN
AZQFJ
BAWUL
BAYMD
BCRHZ
BEYMZ
BGYMP
BHONS
BQDIO
BSCLL
BSWAC
BTRTY
BVRKM
BYORX
BZKNY
C1A
C45
CAG
CASEJ
CDBKE
COF
CS3
CXTWN
CZ4
DAKXR
DFGAJ
DIK
DILTD
DPORF
DPPUQ
DU5
D~K
E3Z
EBS
EE~
EIHJH
EJD
ELUNK
EMOBN
ENERS
F5P
F9B
FECEO
FEDTE
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H5~
HAR
HVGLF
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KBUDW
KC5
KOP
KQ8
KSI
KSN
L7B
M-Z
M49
MBLQV
MBTAY
MHKGH
ML0
N9A
NGC
NLBLG
NOMLY
NOYVH
NTWIH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OBOKY
OCZFY
ODMLO
OHT
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P2P
PAFKI
PB-
PEELM
PQQKQ
Q1.
Q5Y
QBD
R44
RD5
RIG
RNI
ROL
ROX
ROZ
RUSNO
RW1
RXO
RZF
RZO
TCN
TCURE
TEORI
TJX
TLC
TMA
TR2
W8F
WH7
WOQ
X7H
X7M
YAYTL
YKOAZ
YXANX
ZGI
ZKX
ZXP
~91
AAUAY
ABQNK
ADQBN
ATGXG
AANRK
AAPBV
AAUGY
ABPTK
ABXZS
ALXQX
H13
IQODW
OBFPC
AGMDO
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c491t-afa353386dfbcc49386ff83714d190059900a9e39fdbd706d5b9d621a9a8785a3
ISSN 0268-1161
IngestDate Fri Aug 16 23:50:31 EDT 2024
Thu Sep 12 18:11:27 EDT 2024
Thu May 23 23:48:55 EDT 2024
Sun Oct 29 17:08:25 EDT 2023
Wed Sep 11 04:52:16 EDT 2024
Sun Mar 31 11:38:07 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords intrauterine insemination
age
ovulation induction
fertility
Human
Prognosis
Indication
Induction
Artificial insemination
Assisted procreation
Age 40-49
Female
Female sterility
Ovulation
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c491t-afa353386dfbcc49386ff83714d190059900a9e39fdbd706d5b9d621a9a8785a3
Notes ark:/67375/HXZ-NCTNL84P-K
ArticleID:11.5.1109
3To whom correspondence should be addressed
istex:37BDCF7BCDD3F7BBF779A37A134706470F0B9C8F
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/humrep/article-pdf/11/5/1109/1937627/11-5-1109.pdf
PMID 8671400
PQID 78214731
PQPubID 23479
PageCount 4
ParticipantIDs proquest_miscellaneous_78214731
crossref_primary_10_1093_oxfordjournals_humrep_a019306
pubmed_primary_8671400
pascalfrancis_primary_3120779
oup_primary_10_1093_oxfordjournals_humrep_a019306
istex_primary_ark_67375_HXZ_NCTNL84P_K
PublicationCentury 1900
PublicationDate 1996-05-01
PublicationDateYYYYMMDD 1996-05-01
PublicationDate_xml – month: 05
  year: 1996
  text: 1996-05-01
  day: 01
PublicationDecade 1990
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Human reproduction (Oxford)
PublicationTitleAlternate Hum Reprod
PublicationYear 1996
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References 9043930 - Hum Reprod. 1997 Jan;12(1):199
References_xml
SSID ssj0016186
Score 1.737813
Snippet The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has increased...
Abstract The use of ovulation induction combined with intrauterine insemination (IUI) as a treatment for subfertility in women with patent Fallopian tubes has...
SourceID proquest
crossref
pubmed
pascalfrancis
oup
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 1109
SubjectTerms Adult
age
Biological and medical sciences
Birth control
Chorionic Gonadotropin - therapeutic use
Clomiphene - therapeutic use
Female
fertility
Gynecology. Andrology. Obstetrics
Humans
Infertility - therapy
Insemination, Artificial, Homologous
intrauterine insemination
Male
Maternal Age
Medical sciences
Menotropins - therapeutic use
Middle Aged
Ovulation Induction
Pregnancy
Pregnancy Outcome
Pregnancy, High-Risk
Retrospective Studies
Sterility. Assisted procreation
Title Ovulation induction combined with intrauterine insemination in women 40 years of age and older: is it worthwhile?
URI https://api.istex.fr/ark:/67375/HXZ-NCTNL84P-K/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/8671400
https://search.proquest.com/docview/78214731
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKJk1ICEHHRIGBH6AvXTLnO-EFTdVYBWxMopMqXiI7cbQItRlNCiu_jJ_HtZ24KSpo20uUWrIb557YvtfH5yL0miYuceBLMBhh4KBEPDIoY8zgLkuo7TtJKLU7T8_80YX7YeJNOp3fLdbSomJm8mvjuZK7WBXKwK7ilOwtLKsbhQK4B_vCFSwM1xvZ-POPOvnWADxrJQMrOOLg7Dak8lzEbkXWhlyqg5RCSqSpodQXBi4ZLAHuktIhCDwikl6I3N0iWJCXg7waSB7hz0sh4bTOA1RbAEIYs2j-X8iXXivGvI4xDIt5qQKtJ6YOFcD7UZmQW0XFQs4JX8zVPDCd1mmcj81VhEKRmhs-YD2Q2T54qpYSXTe5Gmhdnxi2o0Rn9UhstRDntYZVIYvamqJhfLY3Dv9KGquQvaztVJqXiym8B5PCYtYhG2S3_5oONUlRbc878XpzsWourpu7h7btIPKE238y0eQimYVARfdUz3fQm_r5Dv_7dGuro23xoV83Jy8fXNESPttM5Vv5t0MkF0bjR-hh7dHgIwXPx6jDZ120ewQwK6ZL3MeSYyw3b7po57SmcnRR_1yJpi8P8Hh1BrA8kDW0nPpyF33XKMca5bhBORYox22U4zbK4QeWKMcuwRLluMgwGBcDyrFE-Vuclziv8Arj756gi_fH4-HIqBOFGIkbWZVBM-qA2xL6acYSKIK7LAuFFmUK612hQEQIjbgTZSlLA-KnHotS37ZoRMMg9Kizh7ZmxYw_RRj8bd_iKacuF7JPQWhRm9opuCWEE-pZPeQ3BoqvlB5MfCOg9FBfmlPXovNvglQZePFo8jU-G47PPoXuefyxhyyw920b319Dh67tWDYJgqiHXjVoiWH6EHuCdMaLRRmDg2C5gQP92lMg0lWF8CVM8M_u2uHn6P5qMHiBtqr5gu_DAr5iL-W38gdD2fn4
link.rule.ids 315,786,790,27957,27958
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ovulation+induction+combined+with+intrauterine+insemination+in+women+40+years+of+age+and+older%3A+is+it+worthwhile%3F&rft.jtitle=Human+reproduction+%28Oxford%29&rft.au=Corsan%2C+G.&rft.au=Trias%2C+A.&rft.au=Trout%2C+S.&rft.au=Kemmann%2C+E.&rft.date=1996-05-01&rft.issn=0268-1161&rft.eissn=1460-2350&rft.volume=11&rft.issue=5&rft.spage=1109&rft.epage=1112&rft_id=info:doi/10.1093%2Foxfordjournals.humrep.a019306&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_oxfordjournals_humrep_a019306
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0268-1161&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0268-1161&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0268-1161&client=summon